American Journal of Epidemiology Vol. 109, No. 3: 296-308
Copyright © 1979 by The Johns Hopkins University School of Hygiene and Public Health
other |
HIGH DENSITY LIPOPROTEIN CHOLESTEROL AND INCIDENCE OF CORONARY HEART DISEASE THE ISRAELI ISCHEMIC HEART DISEASE STUDY
1 Department of Research and Sports Medicine, Wingate Institute for Physical Education and Sport Netanya, Israel
2 Department of Family Medicine, Case Western Reserve University 2119 Abington Road, Cleveland, OH 44106
2Send reprint requests to Dr. Medalie at this address.
Using univariate and multivariate analyses, the association between high density lipoprotein (HDL) cholesterol and coronary heart disease (CHD) incidence was investigated. Over 150 cases of myocardial infarction (MI) occurred among 6500 Israeli adult males in a five-year prospective study. At age 50 years and over, there is a significant inverse association between MI incidence and HDL cholesterol. This relationship persists when controlling for risk factors such as age, other cholesterol components, smoking, blood pressure, weight, and diabetes mellitus. Unlike hypercholesterolemia and smoking, the relative risk with HDL cholesterol increases with age above 50. Similar patterns of association occur between HDL cholesterol and angina pectoris incidence, sudden unexpected death and deaths from MI. It is suggested that HDL cholesterol Is an independent risk factor for CHD, especially in males over 50, and the implication of this study is that increased HDL cholesterol might play a protective role in the pathogenesis of CHD.
angina pectoris; cholesterol; coronary disease; lipoproteins; HDL; myocardial infarct; death; sudden
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K.-A. Rye and P. J. Barter Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 421 - 428. [Abstract] [Full Text]
|
|
|
|
|
|
G. Luc, J.-M. Bard, J. Ferrieres, A. Evans, P. Amouyel, D. Arveiler, J.-C. Fruchart, P. Ducimetiere, and on behalf of the PRIME Study Group Value of HDL Cholesterol, Apolipoprotein A-I, Lipoprotein A-I, and Lipoprotein A-I/A-II in Prediction of Coronary Heart Disease: The PRIME Study Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1155 - 1161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Haidar, S. Mott, B. Boucher, C. Y. Lee, M. Marcil, and J. Genest , Jr. Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts J. Lipid Res., February 1, 2001; 42(2): 249 - 257. [Abstract] [Full Text]
|
|
|
|
|
|
B. F. Asztalos, P. S. Roheim, R. L. Milani, M. Lefevre, J. R. McNamara, K. V. Horvath, and E. J. Schaefer Distribution of ApoA-I-Containing HDL Subpopulations in Patients With Coronary Heart Disease Arterioscler Thromb Vasc Biol, December 1, 2000; 20(12): 2670 - 2676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Velez-Carrasco, A. H. Lichtenstein, Z. Li, G. G. Dolnikowski, S. Lamon-Fava, F. K. Welty, and E. J. Schaefer Apolipoprotein A-I and A-II Kinetic Parameters as Assessed by Endogenous Labeling With [2H3]Leucine in Middle-Aged and Elderly Men and Women Arterioscler Thromb Vasc Biol, March 1, 2000; 20(3): 801 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Velez-Carrasco, A. H. Lichtenstein, F. K. Welty, Z. Li, S. Lamon-Fava, G. G. Dolnikowski, and E. J. Schaefer Dietary Restriction of Saturated Fat and Cholesterol Decreases HDL ApoA-I Secretion Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 918 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Boisvert, A. S. Black, and L. K. Curtiss ApoA1 Reduces Free Cholesterol Accumulation in Atherosclerotic Lesions of ApoE–Deficient Mice Transplanted With ApoE–Expressing Macrophages Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 525 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Catalano, E. Perilli, G. Carzaniga, G. Scandale, and M. Carotta Arterial Damage, Triglycerides, Apolipoprotein, and Lp-(a) Values in PVD Patients Clinical and Applied Thrombosis/Hemostasis, April 1, 1997; 3(2): 104 - 109. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Paunio, J. Virtamo, C.-G. Gref, and O. P Heinonen Serum high density lipoprotein cholesterol, alcohol, and coronary mortality in male smokers BMJ, May 11, 1996; 312(7040): 1200 - 1203. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. B. Eaton, J. H. Medalie, S. A. Flocke, S. J. Zyzanski, S. Yaari, and U. Goldbourt Self-reported Physical Activity Predicts Long-term Coronary Heart Disease and All-Cause Mortalities: Twenty-one-Year Follow-up of The Israeli Ischemic Heart Disease Study Arch Fam Med, April 1, 1995; 4(4): 323 - 329. [Abstract] [PDF]
|
|
|
|
 |
|
 The Writing Group for the PEPI Trial, V. T. Miller, J. LaRosa, V. Barnabei, C. Kessler, G. Levin, A. Smith-Roth, M. Griffin, D. B. Stoy, T. Bush, et al. Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial JAMA, January 18, 1995; 273(3): 199 - 208. [Abstract] [PDF]
|
|
|
|
 |
|
 H. B. Rubins, G. Schectman, T. J. Wilt, and M. K. Iwane Distribution of Lipid Phenotypes in Community-Living Men With Coronary Heart Disease: High Prevalence of Isolated Low Levels of High-Density Lipoprotein Cholesterol Arch Intern Med, December 1, 1992; 152(12): 2412 - 2416. [Abstract] [PDF]
|
|
|
|
 |
|
 S. F. Knutsen and R. Knutsen The Tromso Heart Study: Family Approach to Intervention on CHD : sFeasibility of Risk Factor Reduction in High-risk Persons--Project Descriptions Scand J Public Health, April 1, 1989; 17(1): 109 - 119. [Abstract] [PDF]
|
|
|
|
|
|
Z. V. Tran and A. Weltman Differential Effects of Exercise on Serum Lipid and Lipoprotein Levels Seen With Changes in Body Weight: A Meta-analysis JAMA, August 16, 1985; 254(7): 919 - 924. [Abstract] [PDF]
|
|
|
|
|
|
J. T. Salonen, H. Hamynen, U. Leino, E. Kostiainen, and T. Sahi Relation of Alcohol, Physical Activity, Dietary Fat and Smoking to Serum HDL and Total Cholesterol in Young Finnish Men Scand J Public Health, January 1, 1985; 13(3): 99 - 102. [Abstract] [PDF]
|
|
|
|
|
|
P. Khoury, J. A. Morrison, M. J. Mellies, and C. J. Glueck Weight Change Since Age 18 Years in 30- to 55-Year-Old Whites and Blacks: Associations With Lipid Values, Lipoprotein Levels, and Blood Pressure JAMA, December 16, 1983; 250(23): 3179 - 3187. [Abstract] [PDF]
|
|
|
|
 |
|
 L. A. Zech, E. G. Gross, G. L. Peck, and H. B. Brewer Changes in Plasma Cholesterol and Triglyceride Levels After Treatment With Oral Isotretinoin: A Prospective Study Arch Dermatol, December 1, 1983; 119(12): 987 - 993. [Abstract] [PDF]
|
|
|
|
|
|
J. A. Morrison, P. Khoury, M. Mellies, K. Kelly, R. Horvitz, and C. J. Glueck Lipid and Lipoprotein Distributions in Black Adults: The Cincinnati Lipid Research Clinic's Princeton School Study JAMA, March 6, 1981; 245(9): 939 - 942. [Abstract] [PDF]
|
|